Greenbrook Tms, Inc. (GBNHF) has released an update.
Greenbrook TMS Inc. reported a 7% revenue decrease in Q1 2024 to $18 million, attributed to Treatment Center closures and a cyberattack on Change Healthcare. The company experienced a significant rise in operating loss and comprehensive loss, but continued to expand its Spravato® treatment offerings and pilot programs for medication management and talk therapy. Despite these challenges, Greenbrook is optimistic about its restructuring plan and new treatment modalities, aiming to become a comprehensive mental health provider.
For further insights into GBNHF stock, check out TipRanks’ Stock Analysis page.
